QuarterHawk — Equity ResearchQuarterHawk — Equity Research

SelectQuote, Inc. (SLQT)

Financial Services

No action
Fundamental
2
Sentiment
3
Technical
2

Do Nothing: fundamentalScore 2 is below the required floor of 3; independently, avgDollarVolume20 of about $744,463 is below the $5M liquidity floor, the 3-session recent-liquidity average of about $948,903 is below the $1.5M floor, and the max overnight gap of about 5.9% exceeds 5%; both candidate entries were considered — a breakout stop above 0.5237 (R/R about 0.92, under the 1.0 floor) and a pullback limit toward the 0.415-0.421 SMA50/EMA21 cluster (moot, barred by the hard blocks) — and the 1-for-20 reverse split effective 2026-11-17 sits inside the 1-15 day holding window.

Analysis as of 2026-11-15· more than 2 trading days ago

Company overview

SelectQuote, Inc. operates a direct-to-consumer marketplace offering a range of insurance products in the U.S. The company is divided into Senior, Life, and Auto & Home segments, providing Medicare, life, and personal insurance solutions.

Fundamental

weak
Fundamental2
Weak fundamentals

SelectQuote faces severe capital-structure strain with negative GAAP EPS and significant legal and revenue concentration risks.

Weak fundamentals with severe capital-structure strain: a $1.6 billion-revenue Medicare and pharmacy distribution platform whose common equity sits behind $385.8 million of secured debt and a $438.6 million accreted preferred, leaving GAAP EPS negative to common despite reported net income. Revenue has turned down double digits (Q1 fiscal 2027 −15%) after a weak fiscal 2026 whose profit was largely a non-cash warrant mark. A False Claims Act case that survived dismissal, 44% single-carrier revenue concentration, $9.7 million of unrestricted cash and an NYSE sub-$1.00 notice add binary risk. Offsets: positive operating cash flow, term debt maturing 2031, a clean unqualified audit and a November 2026 insider buying cluster at the current price.

Sentiment

fair
Sentiment3
Mixed sentiment

Insider buying is offset by structural challenges, including a reverse split and ongoing legal issues.

Dominant in-window drivers are a 1-for-20 reverse stock split announced 2026-11-13 for NYSE minimum-price compliance (announced, bearish) set against a roughly $0.6M six-insider open-market buying cluster on 2026-11-06/10 (announced, bullish) and a Q1 FY2027 print the tape rewarded with a ~29% pop even though its scored coverage netted negative; the 14-day versus 30–90-day media delta is determinate and flat (polarity ≈ −0.33 on both windows), so sentiment is stably negative rather than deteriorating. The screen is not clean: a moderate red-flag cap applied for genuinely conflicting in-window catalysts and again for confirmed material DOJ False Claims Act litigation, holding the read in the mixed/forming band rather than the top band.

Technical

weak
Technical2
Bounce-only pattern

The stock shows a bounce off lows but remains in a declining trend with an imminent reverse split affecting stability.

technicalScore 2 — bounce-only. The November rebound off the 2026-10-26 low ($0.2999) is real (price now above SMA20/SMA50/EMA21 with MACD line above signal and above zero), but it stalled at $0.5979 on 2026-11-11 and two sessions of distribution have pushed the close below the 9/14/21-term smoothers and below the daily VWAP while the SMA200 keeps falling ($0.774 on 11-02 to $0.724 on 11-13). Momentum is neutral-to-fading (RSI 52.8, Williams -58.9, MACD histogram compressing to 0.01), volatility is extreme (ATR $0.06 = 13.6% of price), and the 1-for-20 reverse split effective 2026-11-17 makes the price series non-stationary across the entire 1-15 day horizon. No trade is admissible: fundamentalScore 2 plus the sub-$5M liquidity floor, the recent-liquidity floor and the overnight-gap gate are independent hard blocks.

You’re looking at 2026-11-15 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.